Mitsuo Egawa

542 total citations
34 papers, 475 citations indexed

About

Mitsuo Egawa is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Mitsuo Egawa has authored 34 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Mitsuo Egawa's work include Neuroscience and Neuropharmacology Research (7 papers), Olfactory and Sensory Function Studies (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Mitsuo Egawa is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Olfactory and Sensory Function Studies (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Mitsuo Egawa collaborates with scholars based in Japan and United States. Mitsuo Egawa's co-authors include Akihiro Tobe, Eric A. Stone, Kenichi Saito, Bartley G. Hoebel, Mitsuru Hashida, Shozo Muranishi, Hitoshi Sezaki, Hiroshi Nakai, Harukazu Fukami and Michikazu Abe and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Life Sciences.

In The Last Decade

Mitsuo Egawa

34 papers receiving 452 citations

Peers

Mitsuo Egawa

CMN

PHARM

PHYSI

D J Jenden United States

Tomio Segawa Japan

Mark J. Benvenga United States

William J. Giardina United States

K. Haba Japan

Sylvie Veiga France

Thomas J. Hudzik United States

Fuller Rw United States

C Morpurgo Italy

Nicola H. Allen United Kingdom

D J Jenden United States

Mitsuo Egawa

272 ×1.1

CMN

223 ×1.2

123 ×1.3

PHARM

25 ×0.4

42 ×0.8

PHYSI

Citations per year, relative to Mitsuo Egawa Mitsuo Egawa (= 1×) peers D J Jenden

Countries citing papers authored by Mitsuo Egawa

Since Specialization

Citations

This map shows the geographic impact of Mitsuo Egawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuo Egawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuo Egawa more than expected).

Fields of papers citing papers by Mitsuo Egawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuo Egawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuo Egawa. The network helps show where Mitsuo Egawa may publish in the future.

Co-authorship network of co-authors of Mitsuo Egawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuo Egawa. A scholar is included among the top collaborators of Mitsuo Egawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuo Egawa. Mitsuo Egawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abe, Michikazu, et al.. (1998). Effect of 5-{3-[((2S)-l,4-Benzodioxan-2-ylmethyl)amino]propoxy}-1,3-benzodioxole HCl (MKC-242), a Novel 5-HT1A-Receptor Agonist, on Aggressive Behavior and Marble Burying Behavior in Mice. The Japanese Journal of Pharmacology. 76(3). 297–304. 35 indexed citations

Matsuda, Toshio, Takashi Yoshikawa, Makoto Suzuki, et al.. (1995). Novel Benzodioxan Derivative, 5-{3-[((2S)-1,4-Benzodioxan-2-ylmethyl)amino]propoxy}-l,3-benzodioxole HC1 (MKC-242), with a Highly Potent and Selective Agonist Activity at Rat Central Serotonin1A Receptors. The Japanese Journal of Pharmacology. 69(4). 357–366. 51 indexed citations

Eguchi, Junichi, et al.. (1995). Effects of MCI-225 on memory and glucose utilization in basal forebrain-lesioned rats. Pharmacology Biochemistry and Behavior. 51(4). 935–939. 7 indexed citations

Eguchi, Junichi, et al.. (1994). Effects of a novel compound MCI-225 on impaired learning and memory in rats. Pharmacology Biochemistry and Behavior. 48(2). 345–349. 10 indexed citations

Egawa, Mitsuo, et al.. (1994). pharmacological profile of MCI-225 on the central nervous system : its antidepressant activity.. The Japanese Journal of Pharmacology. 64. 357–357. 2 indexed citations

Egawa, Mitsuo, et al.. (1993). Radical scavenging action of MCI-186, a new antiischemic agent.. The Japanese Journal of Pharmacology. 61. 211–211. 1 indexed citations

Stone, Eric A., et al.. (1989). Catecholamine-induced desensitization of brain beta adrenoceptors in vivo and reversal by corticosterone. Life Sciences. 44(3). 209–213. 15 indexed citations

Stone, Eric A., Mitsuo Egawa, & Bruce S. McEwen. (1988). Novel effect of chronic corticosterone treatment on escape behavior in rats. Behavioral and Neural Biology. 50(1). 120–125. 16 indexed citations

Egawa, Mitsuo, Bartley G. Hoebel, & Eric A. Stone. (1988). Use of microdialysis to measure brain noradrenergic receptor function in vivo. Brain Research. 458(2). 303–308. 43 indexed citations

10.

Tobe, Akihiro, et al.. (1986). General pharmacological action of 4-(o-Benzylphenoxy)-N-methylamine hydrochloride (bifemelane hydrochloride, MCI-2016) - Influence on the central nervous system.. Folia Pharmacologica Japonica. 87(2). 143–159. 1 indexed citations

11.

Narimatsu, Akihiro, Mitsuo Egawa, Yoshimi Kitada, et al.. (1986). General pharmacological action of 4-(o-Benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016, bifemelane hydrochloride). Influence on respiratory and cardiovascular systems, renal function, autonomic nervous system, isolated smooth muscle and digestive organs.. Folia Pharmacologica Japonica. 87(2). 223–251. 1 indexed citations

12.

Tobe, Akihiro, Mitsuo Egawa, Kenichi Saito, & Noriko Hashimoto. (1985). Effects of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016, bifemelane hydrochloride) on spontaneous motor activity under different experimental conditions.. Folia Pharmacologica Japonica. 86(1). 51–60. 6 indexed citations

13.

Egawa, Mitsuo, Noriko Hashimoto, & Akihiro Tobe. (1985). Effect of MCI-2016 (bifemelane hydrochloride) on cerebral ischemia following ligation of both common carotid arteries in Mongolian gerbils.. Folia Pharmacologica Japonica. 85(6). 487–492. 2 indexed citations

14.

Kano, Akiko, et al.. (1985). Effect of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (bifemelane hydrochloride, MCI-2016) on cerebral glucose metabolism.. Folia Pharmacologica Japonica. 86(6). 425–431. 8 indexed citations

15.

Egawa, Mitsuo, Masayuki Mitsuka, Kohei Umezu, & Akihiro Tobe. (1984). Effects of 4-(o-Benzylphenoxy)-N-Methylbutylamine Hydrochloride (MCI-2016) on Survival Time and Brain Monoamine Levels in Bilaterally Carotid-Artery-Ligated Gerbils. The Japanese Journal of Pharmacology. 34(3). 363–365. 2 indexed citations

16.

Tobe, Akihiro, et al.. (1983). . Folia Pharmacologica Japonica. 81(5). 421–429. 21 indexed citations

17.

Egawa, Mitsuo, et al.. (1983). . Folia Pharmacologica Japonica. 82(5). 351–360. 16 indexed citations

18.

Tobe, Akihiro, et al.. (1983). Effect of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016) on the scopolamine-induced deficit of spontaneous alternation behavior in rats.. The Japanese Journal of Pharmacology. 33(4). 775–784. 37 indexed citations

19.

Tobe, Akihiro, et al.. (1983). EFFECT OF 4-(o-BENZYLPHENOXY)-N-METHYLBUTYLAMINE HYDROCHLORIDE (MCI-2016) ON THE SCOPOLAMINE-INDUCED DEFICIT OF SPONTANEOUS ALTERNATION BEHAVIOR IN RATS. The Japanese Journal of Pharmacology. 33(4). 775–784. 4 indexed citations

20.

Hashida, Mitsuru, Mitsuo Egawa, Shozo Muranishi, & Hitoshi Sezaki. (1977). Role of intramuscular administration of water-in-oil emulsions as a method for increasing the delivery of anticancer to regional lymphatics. Journal of Pharmacokinetics and Biopharmaceutics. 5(3). 225–239. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact